Pfizer PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| BM&FBovespa | BRL | Delayed | ||
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Xetra | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
By Liz Moyer Investing.com -- Stocks were moving higher as tech stocks led the gains, aiming to close out January on a high note. Here are the midday movers for Jan. 31. General...
By Bhanvi Satija and Michael Erman (Reuters) - Pfizer Inc (NYSE:PFE) on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023,...
Pfizer (NYSE:PFE) faces a $16 to $18 billion loss in revenue from 2025 through 2030 as it loses essential patents on five drugs.The drugs account for 40% of the company's Q3...
Investors looking for low cost exchange funds (ETFs) typically put those offered by Vanguard high on their radar screen. In terms of ETF assets under management (AUM), the...
Shares of Pfizer are down over 12.5% since the start of 2022. Plan to spend cash generated from COVID-19 vaccine on M&As and share buybacks. Long-term investors may consider...
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Neutral | Strong Sell | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Neutral | Strong Sell | Sell |
| Summary | Strong Buy | Strong Buy | Neutral | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 60.34 | 60.76 | 57.38 | +2.36 | +4.07% | 2.62M | London | |||
| 1.19 | 1.19 | 1.19 | 0.00 | 0.00% | 0.00 | London | |||
| 230.00 | 230.00 | 230.00 | +2.50 | +1.10% | 17.89K | London | |||
| 1.89 | 1.89 | 1.89 | 0.00 | 0.00% | 0.00 | London | |||
| 12.75 | 12.75 | 12.75 | 0.00 | 0.00% | 0.00 | London | |||
| 177.90 | 178.50 | 178.50 | -0.600 | -0.34% | 1.46K | London | |||
| 1,416.80 | 1,445.00 | 1,405.00 | -6.80 | -0.48% | 1.59M | London | |||
| 10,497.10 | 10,622.90 | 10,473.10 | -92.9 | -0.88% | 31.03K | London | |||
| 236.29 | 238.50 | 226.60 | +3.29 | +1.41% | 533.06K | London | |||
| 3.85 | 3.85 | 3.85 | +0.3500 | +10.14% | 2.85M | London | |||
| 83.33 | 87.50 | 83.10 | -3.50 | -4.04% | 133.64K | London | |||
| 45.14 | 45.43 | 44.02 | +0.94 | +2.13% | 1.53M | London | |||
| 2.177 | 2.177 | 2.177 | +0.150 | +7.50% | 1.39M | London | |||
| 0.45 | 0.46 | 0.38 | +0.06 | +14.65% | 512.93M | London | |||
| 186.62 | 187.03 | 184.68 | +0.78 | +0.42% | 5.46M | London |